Literature DB >> 29110781

Cerebrospinal fluid in the dementias.

Henrik Zetterberg1, Jonathan D Rohrer2, Jonathan M Schott2.   

Abstract

Alzheimer disease, vascular dementia, dementia with Lewy bodies, and frontotemporal dementia are the most common central nervous system disorders that cause progressive neurocognitive dysfunction and ultimately dementia. A number of biomarkers for pathologies reflecting each condition have been developed. Here, we review these and give an overview of the current state of practice and research regarding cerebrospinal fluid biomarkers for these disorders. The chapter discusses both established (most of which are tau- and amyloid β-related) and upcoming biomarkers and details, wherever appropriate, clinical use and differential diagnostics aspects.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Biomarkers; amyloid; cerebrospinal fluid; dementia; dementia with Lewy bodies; frontotemporal dementia; tau; vascular dementia

Mesh:

Substances:

Year:  2017        PMID: 29110781     DOI: 10.1016/B978-0-12-804279-3.00006-X

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  4 in total

Review 1.  Role of Body-Fluid Biomarkers in Alzheimer's Disease Diagnosis.

Authors:  Thuy Trang Nguyen; Qui Thanh Hoai Ta; Thi Kim Oanh Nguyen; Thi Thuy Dung Nguyen; Van Giau Vo
Journal:  Diagnostics (Basel)       Date:  2020-05-20

2.  Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.

Authors:  Kalicharan Patra; Antoninus Soosaipillai; Sigrid Botne Sando; Camilla Lauridsen; Guro Berge; Ina Møller; Gøril Rolfseng Grøntvedt; Geir Bråthen; Ilijana Begcevic; Simon Moussaud; Lennart Minthon; Oskar Hansson; Eleftherios P Diamandis; Linda R White; Henrietta M Nielsen
Journal:  Alzheimers Res Ther       Date:  2018-01-29       Impact factor: 6.982

3.  Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study.

Authors:  Jesper Skov Neergaard; Katrine Dragsbæk; Claus Christiansen; Morten Asser Karsdal; Susanne Brix; Kim Henriksen
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

Review 4.  Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg.

Authors:  Pawel Obrocki; Ayesha Khatun; Deborah Ness; Konstantin Senkevich; Jörg Hanrieder; Federica Capraro; Niklas Mattsson; Ulf Andreasson; Erik Portelius; Nicholas J Ashton; Kaj Blennow; Michael Schöll; Ross W Paterson; Jonathan M Schott; Henrik Zetterberg
Journal:  Alzheimers Res Ther       Date:  2020-02-28       Impact factor: 6.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.